Suven Pharmaceuticals Ltd. (COHANCE): Suven Pharmaceuticals Share Price rises 5.92% today as stock gains
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Suven Pharmaceuticals Share Price moved higher today after the stock closed at Rs 464, up 5.92% from the previous close of Rs 438.05, with market capitalisation at Rs 16,759.68 crore. The day’s move lifted the share price by Rs 25.95, while turnover stood at Rs 4.58 crore. This Suven Pharmaceuticals Share Price update confirms a same-day price rise, but the supplied data does not establish a company-specific catalyst. In that setting, investors tracking Suven Pharmaceuticals Stock News and Suven Pharmaceuticals Share Price Today are left with the verified price move, valuation context and sector comparison. For Univest readers, the event is relevant because the stock is trading in a premium valuation zone versus the same-industry benchmark, while profitability metrics remain modest. The next reference points are the day’s trading range, valuation multiples and the company’s position versus listed pharma peers.
Suven Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 464 |
| Previous Close | Rs 438.05 |
| Today's Move | Rs 25.95 (+5.92%) |
| Open | Rs 438.05 |
| High | Rs 465 |
| Low | Rs 435.95 |
| Turnover | Rs 4.58 crore |
| Market Capitalisation | Rs 16,759.68 crore |
| Market Cap Category | Mid Cap |
Suven Pharmaceuticals Ltd. (COHANCE) rose to Rs 464 from the previous close of Rs 438.05, a move of Rs 25.95 or 5.92%. The stock opened at Rs 438.05, reached a high of Rs 465, recorded a low of Rs 435.95.
Suven Pharmaceuticals Share Price Today showed a clear upward move, opening at Rs 438.05, touching an intraday high of Rs 465 and a low of Rs 435.95 before settling at Rs 464. The stock finished Rs 25.95 above the previous close of Rs 438.05, which translates into a 5.92% share price rise. That places Suven Pharmaceuticals among the Stocks in News and Stocks Rising Today on the Indian Stock Market, based strictly on the day’s price action. The move is also notable because the close sat just below the session high, indicating that the final print remained close to the day’s upper end. Univest tracks such same-day price moves as part of its Suven Pharmaceuticals Stock Analysis and Suven Pharmaceuticals Share Price Live coverage, but the supplied data only confirms the move itself, not the cause.
Suven Pharmaceuticals Ltd. (COHANCE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 16,759.68 crore |
| P/E Ratio | 157.77x |
| P/B Ratio | 4.35x |
| ROE | 4.02% |
| ROCE | 6.12% |
| EPS | Rs 2.78 |
| Book Value Per Share | Rs 100.6 |
| Dividend Yield | 0% |
Suven Pharmaceuticals Ltd. (COHANCE) fundamental metrics show P/E 157.77x, P/B 4.35x, ROE 4.02%, ROCE 6.12%. These figures provide context only and are not a buy or sell signal.
Suven Pharmaceuticals Ltd. has a market capitalisation of Rs 16759.68 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 157.77x, P/B at 4.35x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.02% and ROCE of 6.12%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 2.78, book value per share of Rs 100.6, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 157.77x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 4.35x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 4.02% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 6.12% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 16,759.68 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
Suven Pharmaceuticals Ltd. (COHANCE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Suven Pharmaceuticals Ltd. (COHANCE) has a P/E ratio of 157.77x, which is above the benchmark median of 32.87x, a difference of +379.98%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Suven Pharmaceuticals Ltd. (COHANCE) has a ROE of 4.02%, which is below the benchmark median of 11.7%, a difference of -65.64%. Suven Pharmaceuticals Ltd. (COHANCE) has a ROCE of 6.12%, which is below the benchmark median of 13.46%, a difference of -54.53%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Suven Pharmaceuticals Ltd. (COHANCE) has a P/E ratio of 157.77x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.02% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.12% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Suven Pharmaceuticals Ltd. (COHANCE) has a market capitalisation of Rs 16,759.68 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Suven Pharmaceuticals
- Suven Pharmaceuticals Share Price rose 5.92% today to Rs 464, after opening at Rs 438.05 and closing near the session high of Rs 465.
- Market capitalisation stands at Rs 16,759.68 crore, which is above the same-industry median of Rs 701.78 crore and above the benchmark average of Rs 13,926.75 crore.
- The P/E ratio is 157.77, much higher than the same-industry median of 32.87 and average of 48.77.
- ROE is 4.02% and ROCE is 6.12%, both below the benchmark medians of 11.7% and 13.46%.
- In peer comparison, the stock has a smaller market cap than every supplied peer while carrying the highest P/E in the group.
About Suven Pharmaceuticals Ltd.
Suven Pharmaceuticals Ltd. operates in Healthcare and is classified in the Pharmaceuticals & Drugs industry. The company’s stock trades on NSE and BSE under the symbol COHANCE, and the supplied data points to a business that is being valued well above the industry midpoint. For investors reading Suven Pharmaceuticals Company News, the important business context is that the company sits within a broad pharma universe where revenue, earnings, book value and returns on capital are often compared against established peers. The company’s current market capitalisation, EPS of Rs 2.78, book value of Rs 100.6 and dividend yield of 0.00% provide the most direct financial framing available in this data set. On Univest, that makes Suven Pharmaceuticals Share Price a useful stock to track for both price action and valuation context. Suven Pharmaceuticals Latest News coverage is therefore best read with the sector and peer data rather than in isolation.
Track Suven Pharmaceuticals Share Price on Univest
Use Suven Pharmaceuticals Ltd. (COHANCE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Suven Pharmaceuticals Share Price rise today?
Ans. The data confirms that Suven Pharmaceuticals Share Price rose 5.92% today to Rs 464, but it does not establish a company-specific catalyst. The move can only be read as verified same-day price action.
What is Suven Pharmaceuticals Share Price today?
Ans. Suven Pharmaceuticals Share Price today is Rs 464. It closed above the previous close of Rs 438.05 and finished Rs 25.95 higher, based on the supplied market data. The previous close was Rs 438.05.
How much did Suven Pharmaceuticals stock gain today?
Ans. The stock gained Rs 25.95 in absolute terms and 5.92% in percentage terms. That is a clear same-day price rise, with the close near the intraday high of Rs 465.
What is the market capitalisation of Suven Pharmaceuticals?
Ans. Suven Pharmaceuticals has a market capitalisation of Rs 16,759.68 crore. That places it above the same-industry median and average in the supplied healthcare benchmark set. The company operates in the Healthcare sector.
Is Suven Pharmaceuticals expensive compared with peers?
Ans. On the supplied numbers, Suven Pharmaceuticals trades at a P/E of 157.77, which is higher than every peer shown here. Its P/B of 4.35 is also above some peers and around the sector average.
How do Suven Pharmaceuticals ROE and ROCE compare with the sector?
Ans. Suven Pharmaceuticals reports ROE of 4.02% and ROCE of 6.12%. Both are below the same-industry benchmark medians of 11.7% and 13.46%, which keeps profitability in focus. ROE stands at 4.02%.
Can investors track Suven Pharmaceuticals Share Price on Univest?
Ans. Yes. Univest tracks Suven Pharmaceuticals Share Price Live, valuation ratios, market capitalisation, shareholding pattern, 52-week levels and stock insights in one place for quick monitoring. The previous close was Rs 438.05.
